Showing results (1-10 of 157) with videos related to
Sort By:
Pageof 16
Expert Review of Hematology|May 17, 2019
The role of the thrombopoietin receptor MPL in myeloproliferative neoplasms: recent findings and potential therapeutic applicationsWilliam Vainchenker, Isabelle Plo, Caroline Marty, et al.Frontiers in Endocrinology|September 29, 2017
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting MegakaryopoiesisIsabelle Plo, Christine Bellanné-Chantelot, Matthieu Mosca, et al.Frontiers in Endocrinology|October 6, 2017
Identification of <i>MPL</i> R102P Mutation in Hereditary ThrombocytosisChristine Bellanné-Chantelot, Matthieu Mosca, Caroline Marty, et al.Faculty Reviews|September 29, 2023
Recent advances in therapies for primary myelofibrosisWilliam Vainchenker, Nasrine Yahmi, Violaine Havelange, et al.F1000Research|February 6, 2018
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disordersWilliam Vainchenker, Emilie Leroy, Laure Gilles, et al.Blood Reviews|June 14, 2020
Germline genetic factors in the pathogenesis of myeloproliferative neoplasmsChristine Bellanné-Chantelot, Graciela Rabadan Moraes, Barbara Schmaltz-Panneau, et al.Elife|May 18, 2021
HSPCs display within-family homogeneity in differentiation and proliferation despite population heterogeneityTamar Tak, Giulio Prevedello, Gaël Simon, et al.Clinical Lymphoma & Myeloma|September 26, 2009
Molecular and genetic bases of myeloproliferative disorders: questions and perspectivesIsabelle Plo, William VainchenkerPageof 16